Rapamycin in transplantation: A review of the evidence
Top Cited Papers
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 59 (1), 3-16
- https://doi.org/10.1046/j.1523-1755.2001.00460.x
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- An immunoassay for the measurement of sirolimusClinical Therapeutics, 2000
- PDGF-AA, a Potent Mitogen for Cardiac Fibroblasts from Adult RatsJournal of Molecular and Cellular Cardiology, 1997
- SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1Transplantation, 1996
- The Rapamycin and FKBP12 Target (RAFT) Displays Phosphatidylinositol 4-Kinase ActivityPublished by Elsevier ,1995
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- EFFECTS OF RAPAMYCIN IN EXPERIMENTAL ORGAN ALLOGRAFTINGTransplantation, 1993
- TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RATTransplantation, 1991
- THE IMMUNOSUPPRESSIVE ANTAGONISM OF LOW DOSES OF FK506 AND CYCLOSPORINETransplantation, 1991
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975